Effects of a κ-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans

Silvia Delgado-Aros, Heather J. Chial, Michael Camilleri, Lawrence Szarka, Frank T. Weber, Jutta Jacob, Irene Ferber, Sanna McKinzie, Duane D. Burton, Alan R. Zinsmeister

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

To compare the effects of the κ-opioid agonist asimadoline and placebo on visceral sensation and gastrointestinal (GI) motor functions in humans, 91 healthy participants were randomized in a double-blind fashion to 0.15, 0.5, or 1.5 mg of asimadoline or placebo orally twice a day for 9 days. We assessed satiation (nutrient drink test), colonic compliance, tone, perception of colonic distension (barostat), and whole gut transit (scintigraphy). Treatment effect was assessed by analysis of covariance. Asimadoline increased nutrient drink intake (P = 0.03). Asimadoline decreased colonic tone during fasting (P = 0.03) without affecting postprandial colonic contraction, compliance, or transit. Gas scores in response to colonic distension were decreased with 0.5 mg of asimadoline at low levels (8 mmHg above operating pressure) of distension (P = 0.04) but not at higher levels of distension. Asimadoline at 1.5 mg increased gas scores at 16 mmHg of distension (P = 0.03) and pain scores at distensions of 8 and 16 mmHg (P = 0.003 and 0.03, respectively) but not at higher levels of distension. Further studies of this compound in diseases with altered satiation or visceral sensation are warranted.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume284
Issue number4 47-4
StatePublished - Apr 1 2003

Fingerprint

Satiation
Opioid Analgesics
Compliance
Gases
Placebos
Food
Radionuclide Imaging
asimadoline
Fasting
Healthy Volunteers
Pressure
Pain

Keywords

  • Barostat
  • Colon
  • Sensation
  • Stomach
  • Visceral

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Effects of a κ-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. / Delgado-Aros, Silvia; Chial, Heather J.; Camilleri, Michael; Szarka, Lawrence; Weber, Frank T.; Jacob, Jutta; Ferber, Irene; McKinzie, Sanna; Burton, Duane D.; Zinsmeister, Alan R.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 284, No. 4 47-4, 01.04.2003.

Research output: Contribution to journalArticle

Delgado-Aros, S, Chial, HJ, Camilleri, M, Szarka, L, Weber, FT, Jacob, J, Ferber, I, McKinzie, S, Burton, DD & Zinsmeister, AR 2003, 'Effects of a κ-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans', American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 284, no. 4 47-4.
Delgado-Aros, Silvia ; Chial, Heather J. ; Camilleri, Michael ; Szarka, Lawrence ; Weber, Frank T. ; Jacob, Jutta ; Ferber, Irene ; McKinzie, Sanna ; Burton, Duane D. ; Zinsmeister, Alan R. / Effects of a κ-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2003 ; Vol. 284, No. 4 47-4.
@article{15c5f5f9c8c747949438965a05995000,
title = "Effects of a κ-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans",
abstract = "To compare the effects of the κ-opioid agonist asimadoline and placebo on visceral sensation and gastrointestinal (GI) motor functions in humans, 91 healthy participants were randomized in a double-blind fashion to 0.15, 0.5, or 1.5 mg of asimadoline or placebo orally twice a day for 9 days. We assessed satiation (nutrient drink test), colonic compliance, tone, perception of colonic distension (barostat), and whole gut transit (scintigraphy). Treatment effect was assessed by analysis of covariance. Asimadoline increased nutrient drink intake (P = 0.03). Asimadoline decreased colonic tone during fasting (P = 0.03) without affecting postprandial colonic contraction, compliance, or transit. Gas scores in response to colonic distension were decreased with 0.5 mg of asimadoline at low levels (8 mmHg above operating pressure) of distension (P = 0.04) but not at higher levels of distension. Asimadoline at 1.5 mg increased gas scores at 16 mmHg of distension (P = 0.03) and pain scores at distensions of 8 and 16 mmHg (P = 0.003 and 0.03, respectively) but not at higher levels of distension. Further studies of this compound in diseases with altered satiation or visceral sensation are warranted.",
keywords = "Barostat, Colon, Sensation, Stomach, Visceral",
author = "Silvia Delgado-Aros and Chial, {Heather J.} and Michael Camilleri and Lawrence Szarka and Weber, {Frank T.} and Jutta Jacob and Irene Ferber and Sanna McKinzie and Burton, {Duane D.} and Zinsmeister, {Alan R.}",
year = "2003",
month = "4",
day = "1",
language = "English (US)",
volume = "284",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4 47-4",

}

TY - JOUR

T1 - Effects of a κ-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans

AU - Delgado-Aros, Silvia

AU - Chial, Heather J.

AU - Camilleri, Michael

AU - Szarka, Lawrence

AU - Weber, Frank T.

AU - Jacob, Jutta

AU - Ferber, Irene

AU - McKinzie, Sanna

AU - Burton, Duane D.

AU - Zinsmeister, Alan R.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - To compare the effects of the κ-opioid agonist asimadoline and placebo on visceral sensation and gastrointestinal (GI) motor functions in humans, 91 healthy participants were randomized in a double-blind fashion to 0.15, 0.5, or 1.5 mg of asimadoline or placebo orally twice a day for 9 days. We assessed satiation (nutrient drink test), colonic compliance, tone, perception of colonic distension (barostat), and whole gut transit (scintigraphy). Treatment effect was assessed by analysis of covariance. Asimadoline increased nutrient drink intake (P = 0.03). Asimadoline decreased colonic tone during fasting (P = 0.03) without affecting postprandial colonic contraction, compliance, or transit. Gas scores in response to colonic distension were decreased with 0.5 mg of asimadoline at low levels (8 mmHg above operating pressure) of distension (P = 0.04) but not at higher levels of distension. Asimadoline at 1.5 mg increased gas scores at 16 mmHg of distension (P = 0.03) and pain scores at distensions of 8 and 16 mmHg (P = 0.003 and 0.03, respectively) but not at higher levels of distension. Further studies of this compound in diseases with altered satiation or visceral sensation are warranted.

AB - To compare the effects of the κ-opioid agonist asimadoline and placebo on visceral sensation and gastrointestinal (GI) motor functions in humans, 91 healthy participants were randomized in a double-blind fashion to 0.15, 0.5, or 1.5 mg of asimadoline or placebo orally twice a day for 9 days. We assessed satiation (nutrient drink test), colonic compliance, tone, perception of colonic distension (barostat), and whole gut transit (scintigraphy). Treatment effect was assessed by analysis of covariance. Asimadoline increased nutrient drink intake (P = 0.03). Asimadoline decreased colonic tone during fasting (P = 0.03) without affecting postprandial colonic contraction, compliance, or transit. Gas scores in response to colonic distension were decreased with 0.5 mg of asimadoline at low levels (8 mmHg above operating pressure) of distension (P = 0.04) but not at higher levels of distension. Asimadoline at 1.5 mg increased gas scores at 16 mmHg of distension (P = 0.03) and pain scores at distensions of 8 and 16 mmHg (P = 0.003 and 0.03, respectively) but not at higher levels of distension. Further studies of this compound in diseases with altered satiation or visceral sensation are warranted.

KW - Barostat

KW - Colon

KW - Sensation

KW - Stomach

KW - Visceral

UR - http://www.scopus.com/inward/record.url?scp=0037378287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037378287&partnerID=8YFLogxK

M3 - Article

C2 - 12631557

AN - SCOPUS:0037378287

VL - 284

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 4 47-4

ER -